ResMed | RMD - Operating Profit



ResMed reported $456.57M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Ansell USD 58.65M 19.15M Jun/2024
Avita Medical AUD -9957000 5.64M Dec/2024
Cochlear AUD 274.6M 54.5M Dec/2024
CSL USD 1.98B 778M Dec/2024
Fisher & Paykel Healthcare NZD -371000000 589.1M Mar/2025
Healius AUD -22600000 47.5M Dec/2024
Integral Diagnostics AUD 19.28M 73.95M Jun/2024
Mayne Pharma AUD -3300000 15.67M Jun/2024
Nanosonics AUD 8.7M 6.12M Dec/2024
Polynovo AUD 513K 902K Jun/2024
Ramsay Health Care AUD 200M 285.4M Dec/2024
Regis Healthcare AUD 89.4M 59.65M Dec/2024
ResMed USD 456.57M 39.33M Jun/2025
Sigma Healthcare AUD 6.86M 6.05M Jul/2024
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Telix Pharmaceuticals AUD 17.72M 24.27M Dec/2024